Here’s Why The Cigna Group (CI) Traded Lower in Q3

Cullen Capital Management, LLC, operating under the name Schafer Cullen Capital Management, Inc. (SCCM), has released its “SCCM Value Equity Strategy” third-quarter investor letter. A copy of the letter can be downloaded here. The US equity market continued the rally in the third quarter, with the S&P 500 returning 8.1% and the Russell 1000 Value surging 5.3%. The value equity strategy returned 6.9% (gross of fees) and 6.8% (net of fees) in the quarter, while the Russell 1000 Value and S&P 500 returned 5.3% and 8.1%, respectively, during the same period. The strategy returned 13.0% (gross), YTD, compared to the Russell 1000 Value’s +11.7% return and the S&P 500’s +14.8% return. In addition, you can check the fund’s top 5 holdings to determine its best picks for 2025.

In its third-quarter 2025 investor letter, SCCM Value Equity Strategy highlighted stocks such as The Cigna Group (NYSE:CI). The Cigna Group (NYSE:CI) is a US-based insurance company that offers insurance and related products and services. The one-month return of The Cigna Group (NYSE:CI) was -10.84%, and its shares lost 17.60% of their value over the last 52 weeks. On November 19, 2025, The Cigna Group (NYSE:CI) stock closed at $271.99 per share, with a market capitalization of $72.656 billion.

SCCM Value Equity Strategy stated the following regarding The Cigna Group (NYSE:CI) in its third quarter 2025 investor letter:

“Our stock selection within the Health Care sector detracted from relative performance. The Cigna Group (NYSE:CI) (-12.4%) reported third quarter results that modestly exceeded expectations but reflected continued elevated medical cost trends and softer commercial membership. The company’s medical loss ratio of 83.2% was consistent with broader utilization pressures across managed care, though management reaffirmed full-year guidance and highlighted strong performance in Evernorth’s specialty and care services, including biosimilars and new client growth. Cigna remains comparatively insulated from Medicare and Medicaid headwinds relative to peers, supported by the scale and stability of its pharmacy benefit management and commercial network.”

In another article, we covered The Cigna Group (NYSE:CI) and shared the list of most undervalued large cap stocks to buy. In addition, please check out our hedge fund investor letters Q3 2025 page for more investor letters from hedge funds and other leading investors.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. This article is originally published at Insider Monkey.